Medical and Pharmaceutical Industry - Market Research Report

The global advanced wound care market was valued at USD 11.7 billion in 2025 and is projected to increase from USD 12.1 billion in 2026 to USD 17.8 billion by 2033, registering a compound annual growth rate (CAGR) of 5.4% from 2026 to 2033. Growing surgical volumes, rising incidences of road accidents and traumatic injuries, increasing burn cases, and the development of innovative wound management products are supporting market expansion. North America accounted for 45.5% of global revenue in 2025, while Asia Pacific is expected to record the fastest regional growth over the forecast period, with a CAGR of 6.1%. Key Market Trends & Insights Product and service trends: Moist wound care represented the leading product category, while instruments accounted for the largest reported revenue share of 70.6% in 2025. Application trends: Chronic wounds dominated the application segment, accounting for 59.7% of market revenue in 2025. End-use trends: Hospitals represented the largest end...

The global fill-finish pharmaceutical contract manufacturing market was valued at USD 18.0 billion in 2024 and is expected to reach USD 29.1 billion by 2030, expanding at a CAGR of 8.3% from 2025 to 2030. The market is projected to grow from USD 21.1 billion in 2026 to USD 29.1 billion by 2030. North America held the leading position in 2024, accounting for 34.9% of global revenue. The growing tendency of pharmaceutical and biopharmaceutical companies to outsource fill-finish activities is one of the major factors supporting market expansion. Key Market Trends & Insights Outsourcing becomes a strategic manufacturing model Pharmaceutical companies are increasingly transferring fill-finish activities to specialized contract manufacturing organizations (CMOs). This approach allows drug developers to concentrate resources on core activities such as drug discovery and development while reducing operational complexity, manufacturing risks, and capital requirements. Injectable drug deman...

The global botanical ingredients market was valued at approximately USD 200.4 billion in 2025 and is expected to reach USD 214.5 billion in 2026. By 2033, the market is projected to expand to USD 344.9 billion, representing a 7.0% CAGR from 2026 to 2033. North America accounted for the largest regional revenue share at 34.0% in 2025, while Asia Pacific is expected to record the highest CAGR during the forecast period. What Is Driving Demand for Botanical Ingredients? Growing consumer interest in natural, clean-label, and plant-based products is reshaping demand for botanical ingredients across food and beverages, nutraceuticals, cosmetics, and pharmaceuticals. Greater awareness of preventive healthcare and wellness is also encouraging manufacturers to incorporate plant-derived ingredients into new and existing formulations. Demand is particularly increasing for functional foods, herbal supplements, natural personal care products, and botanical-based functional beverages. Supportive re...

The global medical fiber optics market was valued at USD 4.6 billion in 2022 and is expected to expand from USD 5.7 billion in 2026 to USD 7.3 billion by 2030, registering a CAGR of 6.0% from 2023 to 2030. Asia Pacific led the global market in 2022, accounting for a 31.0% revenue share. Market expansion is being supported by the increasing prevalence of chronic diseases, including cancer, advances in medical device technology, growing awareness of minimally invasive procedures, and improvements in healthcare infrastructure. Market at a Glance The medical fiber optics industry is increasingly benefiting from the integration of optical technologies into diagnostic, surgical, imaging, illumination, and therapeutic medical devices. The growing demand for precise procedures and minimally invasive treatment methods is creating opportunities for fiber optic components and systems across healthcare applications. Medical Fiber Optics Market, 2022–2030 2022 market size: USD 4.6 billion 2026 pr...

The global antimicrobial urinary catheters market was valued at USD 1.2 billion in 2025 and is expected to reach USD 2.3 billion by 2033, expanding at a CAGR of 8.5% from 2026 to 2033. The market is estimated to increase from USD 1.3 billion in 2026 to USD 2.3 billion by 2033. North America led the global market in 2025, accounting for 37.7% of revenue. The primary growth driver is the increasing incidence of catheter-associated urinary tract infections (CAUTIs). Healthcare providers are increasingly adopting antimicrobial urinary catheters to strengthen infection prevention, improve patient safety, and reduce complications in hospitals and home-care environments. What Is Driving Market Growth? The increasing prevalence of chronic conditions that require urinary catheterization is supporting demand for antimicrobial catheter technologies. Conditions such as spinal cord injuries, urinary retention, and neurogenic bladder can increase the need for catheter use and, consequently, infec...

The global companion animal genetics market was valued at USD 855.4 million in 2025 and is expected to reach USD 1,650.5 million by 2033, expanding at a CAGR of 8.7% from 2026 to 2033. The market is forecast to increase from USD 917.5 million in 2026. North America led the global market in 2025, capturing a 30.9% revenue share. Growth in companion animal genetics is being supported by several structural trends, including increasing pet humanization, greater emphasis on preventive veterinary care, wider adoption of direct-to-consumer (DTC) genetic testing, and growing concerns about hereditary and breed-specific diseases. Companion Animal Genetics Market at a Glance Market indicator Value Market size, 2025 USD 855.4 million Market size, 2026 USD 917.5 million Projected market size, 2033 USD 1,650.5 million CAGR, 2026–2033 8.7% Leading region, 2025 North America North America revenue share, 2025 30.9% Fastest-growing region Asia Pacific Source: Grand View Research, IR Documents, Primar...